US Stock MarketDetailed Quotes

Abbott Laboratories (ABT)

Watchlist
  • 84.800
  • +0.970+1.16%
Trading May 14 10:20 ET
147.71BMarket Cap23.75P/E (TTM)

Abbott Laboratories (ABT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.20%1.32B
11.78%9.57B
15.59%3.32B
3.03%2.79B
4.44%2.05B
38.24%1.42B
17.86%8.56B
-5.60%2.87B
44.11%2.71B
62.93%1.96B
Net income from continuing operations
-18.72%1.08B
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
Operating gains losses
----
-86.51%65M
----
----
----
----
282.54%482M
----
----
----
Depreciation and amortization
6.22%803M
-3.17%3.12B
-1.86%792M
-1.25%791M
-3.48%777M
-6.09%756M
-0.77%3.22B
-0.74%807M
-2.79%801M
0.63%805M
Other non cash items
3.67%-420M
----
----
1,104.55%221M
-274.29%-244M
41.71%-436M
----
----
87.71%-22M
121.21%140M
Change In working capital
10.64%-462M
91.29%-803M
101.31%110M
-93.25%11M
4.91%-407M
7.84%-517M
-272.40%-9.22B
-450.59%-8.39B
150.78%163M
3.60%-428M
-Change in receivables
83.97%-42M
5.64%-652M
240.51%222M
-254.39%-202M
-26.15%-410M
-73.51%-262M
-94.10%-691M
-332.35%-158M
87.64%-57M
-65.82%-325M
-Change in inventory
-64.71%-420M
436.21%195M
-0.43%234M
-3.18%213M
102.91%3M
37.80%-255M
75.00%-58M
-20.34%235M
57.14%220M
58.47%-103M
-Change in prepaid assets
----
-62.69%-1.3B
----
----
----
----
-46.86%-796M
----
----
----
-Change in payables and accrued expense
----
112.37%949M
----
----
----
----
-470.41%-7.67B
----
----
----
Cash from discontinued investing activities
Operating cash flow
-7.20%1.32B
11.78%9.57B
15.59%3.32B
3.03%2.79B
4.44%2.05B
38.24%1.42B
17.86%8.56B
-5.60%2.87B
44.11%2.71B
62.93%1.96B
Investing cash flow
Cash flow from continuing investing activities
-4,224.26%-20.32B
-3.59%-2.42B
-5.43%-913M
23.06%-457M
-28.48%-582M
-10.59%-470M
25.38%-2.34B
-5.10%-866M
6.31%-594M
62.65%-453M
Net PPE purchase and sale
17.56%-399M
1.63%-2.17B
4.31%-689M
10.79%-496M
5.82%-502M
-21.61%-484M
-0.23%-2.21B
4.64%-720M
0.71%-556M
-5.13%-533M
Net business purchase and sale
---19.8B
-10,600.00%-105M
---20M
---55M
---30M
--0
100.12%1M
--0
--0
----
Net investment purchase and sale
-2,112.50%-161M
-16.31%-164M
-40.00%-210M
325.00%90M
-167.53%-52M
128.57%8M
-21.55%-141M
-111.27%-150M
-5.26%-40M
-2.53%77M
Net other investing changes
466.67%34M
100.00%18M
50.00%6M
100.00%4M
0.00%2M
500.00%6M
-59.09%9M
100.00%4M
-86.67%2M
100.00%2M
Cash from discontinued investing activities
Investing cash flow
-4,224.26%-20.32B
-3.59%-2.42B
-5.43%-913M
23.06%-457M
-28.48%-582M
-10.59%-470M
25.38%-2.34B
-5.10%-866M
6.31%-594M
62.65%-453M
Financing cash flow
Cash flow from continuing financing activities
942.48%17.31B
-16.75%-6.31B
24.93%-1.4B
-11.68%-1.76B
-38.69%-1.1B
-74.74%-2.06B
23.79%-5.4B
9.31%-1.86B
32.65%-1.58B
38.63%-791M
Net issuance payments of debt
1,883.30%18.48B
-200.56%-1.61B
88.58%-70M
-1,246.51%-493M
-109.38%-15M
-715.75%-1.04B
78.30%-537M
34.72%-613M
102.86%43M
1,233.33%160M
Net common stock issuance
35.71%-180M
31.04%-893M
4.13%-302M
59.39%-305M
-100.00%-6M
-23.89%-280M
-5.54%-1.3B
-21.62%-315M
-37,450.00%-751M
99.30%-3M
Cash dividends paid
-7.02%-1.1B
-7.30%-4.12B
-7.52%-1.03B
-7.40%-1.03B
-7.08%-1.03B
-7.21%-1.03B
-7.87%-3.84B
-7.88%-958M
-8.11%-960M
-7.98%-961M
Proceeds from stock option exercised by employees
-59.58%116M
50.00%396M
-80.00%5M
-25.00%69M
169.23%35M
114.18%287M
58.08%264M
-26.47%25M
64.29%92M
-13.33%13M
Net other financing activities
----
---82M
--0
--0
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
942.48%17.31B
-16.75%-6.31B
24.93%-1.4B
-11.68%-1.76B
-38.69%-1.1B
-74.74%-2.06B
23.79%-5.4B
9.31%-1.86B
32.65%-1.58B
38.63%-791M
Net cash flow
Beginning cash position
11.90%8.52B
10.44%7.62B
-0.62%7.51B
-0.52%6.95B
3.95%6.53B
10.44%7.62B
-30.22%6.9B
12.65%7.56B
-10.82%6.99B
-31.40%6.28B
Current changes in cash
-53.07%-1.7B
2.33%835M
612.77%1.01B
6.54%570M
-48.60%368M
-92.36%-1.11B
127.54%816M
-12.96%141M
148.77%535M
155.12%716M
Effect of exchange rate changes
-195.83%-23M
173.96%71M
107.23%6M
-127.78%-10M
492.31%51M
166.67%24M
-317.39%-96M
-432.00%-83M
224.14%36M
51.85%-13M
End cash Position
4.15%6.8B
11.90%8.52B
11.90%8.52B
-0.62%7.51B
-0.52%6.95B
3.95%6.53B
10.44%7.62B
10.44%7.62B
12.65%7.56B
-10.82%6.99B
Free cash flow
-1.82%916M
16.44%7.4B
22.25%2.63B
6.61%2.29B
8.27%1.55B
48.80%933M
25.54%6.35B
-5.91%2.15B
63.17%2.15B
105.03%1.43B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.20%1.32B11.78%9.57B15.59%3.32B3.03%2.79B4.44%2.05B38.24%1.42B17.86%8.56B-5.60%2.87B44.11%2.71B62.93%1.96B
Net income from continuing operations -18.72%1.08B-51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B
Operating gains losses -----86.51%65M----------------282.54%482M------------
Depreciation and amortization 6.22%803M-3.17%3.12B-1.86%792M-1.25%791M-3.48%777M-6.09%756M-0.77%3.22B-0.74%807M-2.79%801M0.63%805M
Other non cash items 3.67%-420M--------1,104.55%221M-274.29%-244M41.71%-436M--------87.71%-22M121.21%140M
Change In working capital 10.64%-462M91.29%-803M101.31%110M-93.25%11M4.91%-407M7.84%-517M-272.40%-9.22B-450.59%-8.39B150.78%163M3.60%-428M
-Change in receivables 83.97%-42M5.64%-652M240.51%222M-254.39%-202M-26.15%-410M-73.51%-262M-94.10%-691M-332.35%-158M87.64%-57M-65.82%-325M
-Change in inventory -64.71%-420M436.21%195M-0.43%234M-3.18%213M102.91%3M37.80%-255M75.00%-58M-20.34%235M57.14%220M58.47%-103M
-Change in prepaid assets -----62.69%-1.3B-----------------46.86%-796M------------
-Change in payables and accrued expense ----112.37%949M-----------------470.41%-7.67B------------
Cash from discontinued investing activities
Operating cash flow -7.20%1.32B11.78%9.57B15.59%3.32B3.03%2.79B4.44%2.05B38.24%1.42B17.86%8.56B-5.60%2.87B44.11%2.71B62.93%1.96B
Investing cash flow
Cash flow from continuing investing activities -4,224.26%-20.32B-3.59%-2.42B-5.43%-913M23.06%-457M-28.48%-582M-10.59%-470M25.38%-2.34B-5.10%-866M6.31%-594M62.65%-453M
Net PPE purchase and sale 17.56%-399M1.63%-2.17B4.31%-689M10.79%-496M5.82%-502M-21.61%-484M-0.23%-2.21B4.64%-720M0.71%-556M-5.13%-533M
Net business purchase and sale ---19.8B-10,600.00%-105M---20M---55M---30M--0100.12%1M--0--0----
Net investment purchase and sale -2,112.50%-161M-16.31%-164M-40.00%-210M325.00%90M-167.53%-52M128.57%8M-21.55%-141M-111.27%-150M-5.26%-40M-2.53%77M
Net other investing changes 466.67%34M100.00%18M50.00%6M100.00%4M0.00%2M500.00%6M-59.09%9M100.00%4M-86.67%2M100.00%2M
Cash from discontinued investing activities
Investing cash flow -4,224.26%-20.32B-3.59%-2.42B-5.43%-913M23.06%-457M-28.48%-582M-10.59%-470M25.38%-2.34B-5.10%-866M6.31%-594M62.65%-453M
Financing cash flow
Cash flow from continuing financing activities 942.48%17.31B-16.75%-6.31B24.93%-1.4B-11.68%-1.76B-38.69%-1.1B-74.74%-2.06B23.79%-5.4B9.31%-1.86B32.65%-1.58B38.63%-791M
Net issuance payments of debt 1,883.30%18.48B-200.56%-1.61B88.58%-70M-1,246.51%-493M-109.38%-15M-715.75%-1.04B78.30%-537M34.72%-613M102.86%43M1,233.33%160M
Net common stock issuance 35.71%-180M31.04%-893M4.13%-302M59.39%-305M-100.00%-6M-23.89%-280M-5.54%-1.3B-21.62%-315M-37,450.00%-751M99.30%-3M
Cash dividends paid -7.02%-1.1B-7.30%-4.12B-7.52%-1.03B-7.40%-1.03B-7.08%-1.03B-7.21%-1.03B-7.87%-3.84B-7.88%-958M-8.11%-960M-7.98%-961M
Proceeds from stock option exercised by employees -59.58%116M50.00%396M-80.00%5M-25.00%69M169.23%35M114.18%287M58.08%264M-26.47%25M64.29%92M-13.33%13M
Net other financing activities -------82M--0--0------------------------
Cash from discontinued financing activities
Financing cash flow 942.48%17.31B-16.75%-6.31B24.93%-1.4B-11.68%-1.76B-38.69%-1.1B-74.74%-2.06B23.79%-5.4B9.31%-1.86B32.65%-1.58B38.63%-791M
Net cash flow
Beginning cash position 11.90%8.52B10.44%7.62B-0.62%7.51B-0.52%6.95B3.95%6.53B10.44%7.62B-30.22%6.9B12.65%7.56B-10.82%6.99B-31.40%6.28B
Current changes in cash -53.07%-1.7B2.33%835M612.77%1.01B6.54%570M-48.60%368M-92.36%-1.11B127.54%816M-12.96%141M148.77%535M155.12%716M
Effect of exchange rate changes -195.83%-23M173.96%71M107.23%6M-127.78%-10M492.31%51M166.67%24M-317.39%-96M-432.00%-83M224.14%36M51.85%-13M
End cash Position 4.15%6.8B11.90%8.52B11.90%8.52B-0.62%7.51B-0.52%6.95B3.95%6.53B10.44%7.62B10.44%7.62B12.65%7.56B-10.82%6.99B
Free cash flow -1.82%916M16.44%7.4B22.25%2.63B6.61%2.29B8.27%1.55B48.80%933M25.54%6.35B-5.91%2.15B63.17%2.15B105.03%1.43B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More